Guillain–Barré syndrome due to hepatitis E

2018 ◽  
Vol 174 (1-2) ◽  
pp. 72-74 ◽  
Author(s):  
A.C. Troussière ◽  
V. Sudaveschi ◽  
P. Collardelle ◽  
S. Marque Julliet ◽  
J. Servan ◽  
...  
2014 ◽  
Vol 2 (1) ◽  
pp. 48-49
Author(s):  
Poly Sengupta ◽  
Rama Biswas ◽  
Hasan Shahrear Ahmed ◽  
Kaniz Fatema

Guillain- Barrè Syndrome is characterized by acute progressive symmetric limb weakness and areflexia. A 32 year old female presented with progressive ascending areflexic muscular weakness and bilateral lower motor neuron type of facial palsy. She had anorexia, nausea and upper abdominal pain for 2 weeks. The findings of motor nerve conduction study are consistent with acute inflammatory demyelinating polyradiculoneuropathy. She had elevated liver enzyme and positive immunoglobulin M antibody against hepatitis E in blood. Based on clinical features, laboratory findings and electrophysiological study, she was diagnosed as Guillain- Barrè Syndrome following hepatitis E. She was treated with intravenous immunoglobulin and recovered fully. DOI: http://dx.doi.org/10.3329/bccj.v2i1.19973 Bangladesh Crit Care J March 2014; 2 (1): 48-49


Infection ◽  
2011 ◽  
Vol 40 (3) ◽  
pp. 323-326 ◽  
Author(s):  
I. Maurissen ◽  
A. Jeurissen ◽  
T. Strauven ◽  
D. Sprengers ◽  
B. De Schepper

2012 ◽  
Vol 19 (4) ◽  
pp. 607-608 ◽  
Author(s):  
Alan C.T. Tse ◽  
Raymond T.F. Cheung ◽  
Shu Leong Ho ◽  
Koon Ho Chan

2014 ◽  
Vol 35 (9) ◽  
pp. 1461-1463 ◽  
Author(s):  
Xiao-Dong Chen ◽  
Ye-Ting Zhou ◽  
Jin-Jin Zhou ◽  
Yuan-Wei Wang ◽  
Dao-Ming Tong

2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
Dhrubajyoti Bandyopadhyay ◽  
Vijayan Ganesan ◽  
Cankatika Choudhury ◽  
Suvrendu Sankar Kar ◽  
Parthasarathi Karmakar ◽  
...  

We are presenting two cases of Guillain-Barré syndrome where it is preceded by hepatitis E virus (HEV) and Japanese encephalitis virus (JEV) infection, respectively. Our first case is a forty-three-year-old nondiabetic, nonhypertensive female who was initially diagnosed with acute HEV induced viral hepatitis and subsequently developed acute onset ascending quadriparesis with lower motor neuron type of bilateral facial nerve palsies and respiratory failure. Second patient was a 14-year-old young male who presented with meningoencephalitis with acute onset symmetric flaccid paraparesis. After thorough investigations it was revealed as a case of Japanese encephalitis. Our idea of reporting these two cases is to make ourselves aware about this potential complication of these two common infections.


2017 ◽  
Vol 142 (11) ◽  
pp. 833-837
Author(s):  
Heiner Wedemeyer

Was ist neu? Übertragungswege In Deutschland infizieren sich jedes Jahr wahrscheinlich mehr als 300 000 Menschen mit dem Hepatitis-E-Virus (HEV). Die Hepatitis E ist in Mitteleuropa in der Regel eine durch den zoonotischen HEV-Genotyp-3-verursachte autochthone, d. h. lokal erworbene Infektionskrankheit. Der Verzehr von nicht ausreichend erhitztem Schweine- oder Wildfleisch ist ein Hauptrisikofaktor für HEV-Infektionen, Übertragungen des Virus durch Bluttransfusionen sind aber auch möglich. Diagnostik Bei Immunkompetenten kann die Diagnose einer akuten Hepatitis E mit dem Nachweis von anti-HEV-IgM gestellt werden. Serologische Tests können bei Immunsupprimierten aber falsch-negativ sein, weshalb in diesen Fällen eine HEV-Infektion nur durch den direkten Nachweis des Erregers mittels PCR im Blut oder Stuhl erfolgen sollte. Natürlicher Verlauf Eine akute Hepatitis E kann bei Patienten mit anderen chronischen Lebererkrankungen zu einem Leberversagen führen. Chronische Verläufe, definiert durch eine Virämie von mind. 3 Monaten, sind bei Organtransplantierten mit immunsuppressiver Medikation beschrieben, können aber auch bei anderen Immundefizienzen auftreten. Eine chronische Hepatitis E kann innerhalb von Monaten zu einer fortgeschrittenen Leberfibrose oder zur Zirrhose führen. Extrahepatische Manifestationen Extrahepatische Manifestationen können während und nach einer HEV-Infektion auftreten. Insbesondere Guillain-Barré-Syndrome und die neuralgische Schulteramyotrophie sind mit einer Hepatitis E assoziiert worden. Therapie Ribavirin hat eine antivirale Wirksamkeit gegen HEV. Bei chronischer Hepatitis E sollte die Behandlung für 3 – 6 Monate durchgeführt werden. Therapieversagen und Rückfälle nach Beendigung einer Behandlung sind möglich. Ein Impfstoff gegen HEV ist bisher nur in China zugelassen.


2017 ◽  
Vol 74 (1) ◽  
pp. 13 ◽  
Author(s):  
Kenneth L. Tyler ◽  
Daniel M. Pastula

BMC Neurology ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Miriam Fritz-Weltin ◽  
Estelle Frommherz ◽  
Nora Isenmann ◽  
Lisa Niedermeier ◽  
Benedikt Csernalabics ◽  
...  

Abstract Background Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis worldwide. An association with neuralgic amyotrophy and Guillain-Barré syndrome (GBS) was previously described. Concerning GBS, studies from other countries found an acute HEV infection in 5–11% of cases. However, HEV prevalence shows considerable regional variations. Therefore, we retrospectively analyzed the frequency of HEV infections in association with GBS in a monocentric cohort in Southwestern Germany. Methods Overall, 163 patients with GBS treated in our clinic between 2008 and 2018 of whom serum and/or cerebrospinal fluid (CSF) samples were available, were identified. Serum samples were analyzed for anti-HEV immunoglobulin (Ig)M and IgG antibodies by ELISA. Additionally, both serum and cerebrospinal fluid (CSF) samples were tested for HEV RNA by PCR if IgM was positive or patients presented within the first 7 days from GBS symptom onset. A group of 167 healthy volunteers and 96 healthy blood donors served as controls. Results An acute HEV infection was found in two GBS patients (1.2%) with anti-HEV IgM and IgG antibodies. HEV PCR in serum and CSF was negative in these two patients as well as in all other tested cases. Seroprevalences indicated that acute infection did not differ significantly from controls (0.8%). Anti-HEV IgG seroprevalence indicating previous infection was unexpectedly high (41%) and revealed an age-dependent increase to more than 50% in patients older than 60 years. Conclusion In this study, serological evidence of an acute HEV infection in patients with GBS was rare and not different from controls. Comparing our data with previous studies, incidence rates show considerable regional variations.


2013 ◽  
Vol 18 (34) ◽  
Author(s):  
L Santos ◽  
J R Mesquita ◽  
N Rocha Pereira ◽  
C Lima-Alves ◽  
R Serrão ◽  
...  

Binary file ES_Abstracts_Final_ECDC.txt matches


Author(s):  
Monami Tarisawa ◽  
Ryo Ando ◽  
Katsuki Eguchi ◽  
Megumi Abe ◽  
Masaaki Matsushima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document